公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2019 | Efficacy and safety of 12 weeks of daclatasvir, asunaprevir plus ribavirin for HCV genotype-1b infection without NS5A resistance-associated substitutions | Yu M.-L.; Hung C.-H.; Huang Y.-H.; Peng C.-Y.; Lin C.-Y.; Cheng P.-N.; Chien R.-N.; SHIH-JER HSU ; CHEN-HUA LIU ; Huang C.-F.; Su C.-W.; Huang J.-F.; CHUN-JEN LIU ; JIA-HORNG KAO ; Chuang W.-L.; PEI-JER CHEN ; DING-SHINN CHEN | Journal of the Formosan Medical Association | 10 | 8 | |
2010 | Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma | CHIH-HUNG HSU ; Yang T.-S.; CHIUN HSU ; Toh H.C.; Epstein R.J.; Hsiao L.-T.; PEI-JER CHEN ; ZHONG-ZHE LIN ; Chao T.-Y.; ANN-LII CHENG | British Journal of Cancer | 114 | 112 | |
2000 | Efficacy of consensus interferon in the treatment of chronic hepatitis C | JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Journal of Gastroenterology and Hepatology (Australia) | 12 | 7 | |
2018 | Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected With HBV | CHUN-JEN LIU ; Chuang W.-L.; Sheen I.-S.; Wang H.-Y.; Chen C.-Y.; Tseng K.-C.; Chang T.-T.; Massetto B.; Yang J.C.; Yun C.; Knox S.J.; Osinusi A.; Camus G.; Jiang D.; Brainard D.M.; McHutchison J.G.; Hu T.-H.; Hsu Y.-C.; Lo G.-H.; Chu C.-J.; Chen J.-J.; Peng C.-Y.; Chien R.-N.; PEI-JER CHEN | Gastroenterology | 95 | 82 | |
2020 | Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis | CHEN-HUA LIU ; Peng C.-Y.; YU-JEN FANG ; Kao W.-Y.; Yang S.-S.; Lin C.-K.; Lai H.-C.; Su W.-P.; Fang S.-U.; Chang C.-C.; TUNG-HUNG SU ; CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Scientific Reports | 8 | 6 | |
2005 | Electrical detection of DNA hybridization with multilayer gold nanoparticles between nanogap electrodes | Tsai C.-Y.; Tsai Y.-H.; Pun C.-C.; Chan B.; Luh T.-Y.; Chen C.-C.; Ko F.-H.; PEI-JER CHEN ; Chen P.-H. | Microsystem Technologies | 22 | 21 | |
2015 | Elevated p53 promotes the processing of miR-18a to decrease estrogen receptor-α in female hepatocellular carcinoma | Li C.-L.; KUN-HUEI YEH ; Liu W.-H.; CHI-LING CHEN ; DING-SHINN CHEN ; PEI-JER CHEN ; Shiou-Hwei Yeh | International Journal of Cancer | 39 | 35 | |
2020 | Elimination of hepatitis B in highly endemic settings: Lessons learned in Taiwan and challenges ahead | CHUN-JEN LIU ; PEI-JER CHEN | Viruses | 25 | 19 | |
2012 | Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia | Afdhal N.H.; Giannini E.G.; Tayyab G.; Mohsin A.; Lee J.-W.; Andriulli A.; Jeffers L.; McHutchison J.; PEI-JER CHEN ; Han K.-H.; Campbell F.; Hyde D.; Brainsky A.; Theodore D. | New England Journal of Medicine | 240 | 215 | |
2014 | Eltrombopag increases platelet numbers in thrombocytopenic patients with hcv infection and cirrhosis, allowing for effective antiviral therapy | Afdhal N.H.; Dusheiko G.M.; Giannini E.G.; PEI-JER CHEN ; Han K.-H.; Mohsin A.; Rodriguez-Torres M.; Rugina S.; Bakulin I.; Lawitz E.; Shiffman M.L.; Tayyab G.-U.-N.; Poordad F.; Kamel Y.M.; Brainsky A.; Geib J.; Vasey S.Y.; Patwardhan R.; Campbell F.M.; Theodore D. | Gastroenterology | 104 | 103 | |
2012 | Emerging hepatitis B virus infection in vaccinated populations: A rising concern? | TUNG-HUNG SU ; PEI-JER CHEN | Emerging Microbes and Infections | 13 | 10 | |
2004 | End-of-treatment virologic response does not predict relapse after lamivudine treatment for chronic hepatitis B | CHUN-JEN LIU ; Huang W.-L.; PEI-JER CHEN ; Lai M.-Y.; JIA-HORNG KAO ; DING-SHINN CHEN | World Journal of Gastroenterology | 14 | 12 | |
2004 | Enhancement of vaccinia vaccine potency by linkage of tumor antigen gene to gene encoding calreticulin | Hsieh C.-J.; Kim T.W.; Hung C.-F.; Juang J.; Moniz M.; Boyd D.A.K.; He L.; PEI-JER CHEN ; CHIEN-HUNG CHEN ; Wu T.-C. | Vaccine | 58 | 56 | |
2022 | Entecavir Prevents HBV Reactivation During Direct Acting Antivirals for HCV/HBV Dual Infection: A Randomized Trial | Cheng P.-N.; CHUN-JEN LIU ; Chen C.-Y.; Tseng K.-C.; Lo C.-C.; Peng C.-Y.; Lin C.-L.; Chiu H.-C.; Chiu Y.-C.; PEI-JER CHEN | Clinical Gastroenterology and Hepatology | 7 | 7 | |
1996 | Envelope gene sequences of human T-lymphotropic virus type I in Taiwan | Lin M.T.; Chen Y.C.; PEI-JER CHEN ; YA-CHIEN YANG ; JIH-LUH TANG ; Wu J.M.; Chuang S.E.; Yang C.S. | Archives of Virology | 10 | 9 | |
2004 | Epidemiologic features of Kawasaki disease in Taiwan, 1996-2002 | LUAN-YIN CHANG ; Chang I.-S.; CHUN-YI LU ; BOR-LUEN CHIANG ; CHIN-YUN LEE ; PEI-JER CHEN ; JIN-TOWN WANG ; HONG-NERNG HO ; DING-SHINN CHEN ; LI-MIN HUANG | Pediatrics | 92 | 77 | |
2009 | Epidemiologic features of Kawasaki disease in Taiwan, 2003 2006 | Huang W.-C.; LI-MIN HUANG ; Chang I.-S.; LUAN-YIN CHANG ; BOR-LUEN CHIANG ; PEI-JER CHEN ; MEI-HWAN WU ; Lue H.-C.; Lee C.-Y. | Pediatrics | 212 | 182 | |
2006 | Epidemiology of HBV infection in Asian blood donors: Emphasis on occult HBV infection and the role of NAT | CHUN-JEN LIU ; DING-SHINN CHEN ; PEI-JER CHEN | Journal of Clinical Virology | 105 | 95 | |
2005 | Epigenetic activation of α4, β2 and β6 integrins involved in cell migration in trichostatin A-treated Hep3B cells | Lin K.-T.; Shiou-Hwei Yeh ; DING-SHINN CHEN ; PEI-JER CHEN ; Jou Y.-S. | Journal of Biomedical Science | 24 | 25 | |
2008 | ERK1/2-mediated phosphorylation of small hepatitis delta antigen at serine 177 enhances hepatitis delta virus antigenomic RNA replication | Chen Y.-S.; Huang W.-H.; Hong S.-Y.; Tsay Y.-G.; PEI-JER CHEN | Journal of Virology | 18 | 15 |